Archived Grant Opportunity View - GO1438

The Biomedical Translation Bridge grant opportunity will support one or more organisations to fund and nurture early stage health and medical research ventures to reach proof-of-concept stage with potential to attract further capital and support.

It will provide $22.3 million over four years from 2018-19 to 2021-22 as follows:

• $10.4 million in 2018-19
• $5.3 million in 2019-20
• $5.3 million in 2020-21
• $1.3 million in 2021-22.

The grant amount will be up to 100 per cent of eligible expenditure. It is expected that to be competitive, applicants will also provide co-funding towards this program that at least matches the level of funding to be provided to you through this grant opportunity.

To be an eligible organisation you must:

• have an Australian Business Number (ABN)
• be registered for the Goods and Services Tax (GST)
• be incorporated in Australia,

and, in accordance with s24 of the Medical Research Future Fund Act 2015, you must be one of the following eligible bodies:

• a medical research institute
• a university
• a corporate Commonwealth entity
• a corporation (including businesses and not for profits).

You are not eligible to apply if you are:

• an individual
• a partnership
• a trust (however, an incorporated trustee may apply on behalf of a trust)
• a Commonwealth, state, territory or local government body (including government business enterprises) other than a corporate commonwealth entity.

To be eligible your project must:

• include eligible activities and eligible expenditure
• select, provide funding to, and manage a portfolio of ventures
• provide mentoring and networking capabilities to aid in the development of these ventures, including helping to establish development milestones that are commercially relevant
• solicit and secure relevant and appropriate philanthropic donations and third party sponsorship or co-investment and then provide this to the selected ventures to aid in their development
• select successful ventures, through an open and competitive selection process, with possible subsequent intake rounds or a continuous intake process
• establish a suitably qualified selection panel, in consultation with the department and the Department of Health, that will be used to select ventures to be funded
• execute and manage contractual arrangements with the selected ventures (between $200,000 and $1 million with a maximum duration of three years) including terminating funding and support for ventures that fail to progress
• be able to start in early 2018-19.

$22,300,000.00

To apply, go to https://www.business.gov.au/biomedical-translation-bridge

business.gov.au provides information and advice to customers via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.